Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

    Data Compilation
    #PharmaFlow

    Pipeline Prospector July 2025: Merck to acquire Verona for US$ 10 bn; FDA okays Regeneron’s blood cancer med

    Stock Recap
    #PipelineProspector

    Menu

    Remeron, Avanza, Zispin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 375Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/08/2025 Aspen API
    Netherlands
    		 ASPEN OSS B.V. Oss NL R1-CEP 2010-016 - Rev 03 Mirtazapine 2022-12-15 Valid Chemical 2338
    28/08/2025 Maithri Drugs
    India
    		 MAITHRI DRUGS PRIVATE LIMITED Bonthapally Village IN CEP 2018-225 - Rev 01 Mirtazapine, Route code "ZA" 2024-04-10 Valid Chemical 2338